Investment
Investment makes the pharma world go ‘round. We summarize funding dollars and trends from government, venture, private equity, and big pharma.
As investors and former investors ourselves, Nice Insight takes the investment news and provides context. We walk through the numbers but also provide our opinion of the state of the market. Our opinion comes from discussions with investors, strategic leaders, and years of experience in the pharma market. Our clients rely on our personalized advice to make critical decisions regarding their firms, but you can read our opinions of the overall market here.